We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

News   Jun 21, 2018 | Original story from PhoreMost

 
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

Dr Chris Torrance, CEO at PhoreMost Ltd

 
 
 

RELATED ARTICLES

Protein “Trafficker” Implicated in Autism and Other Brain Disorders

News

Findings suggest that protein ASTN2 is a key regulator of dynamic trafficking of synaptic proteins and lend support to the idea that aberrant regulation of protein homeostasis in neurons is a contributing cause of complex neurodevelopmental disorders.

READ MORE

Trojan Horse Delivery for Treating Rare Blood-clotting Disorder

News

Platelet blood cells can carry an enzyme needed to prevent clots, while hiding it from autoantibody neutralization.

READ MORE

Understanding What Makes Us Hot

News

A microdialysis study on mice aimed to determine mechanisms underlying the inflammatory response in the brain associated with fever that might be used to develop new strategies for treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE